ANTI-INFLAMMATORY COMPOSITIONS Russian patent published in 2017 - IPC A61K38/20 A61P29/00 

FIELD: medicine.

SUBSTANCE: method for inflammatory condition treatment includes sublingual introduction of interleukin-2 (IL-2) at a dose of 4000 IU to 12000 IU per day, and where the inflammatory condition is selected from arthritis, sinusitis, allergic disorders, psoriasis, acne, inflammatory bowel disease, chronic fatigue syndrome, autoimmune disorders, Sjogren syndrome, prostate gland inflammation, urinary tract inflammation, pancreatitis, vasculitis, diabetes, gout or accompanying state and periodic pain. The group of inventions also concerns the use of interleukin-2 (IL-2) for inflammatory conditions treatment, where the drug is injected sublingually at a dose of 4000 IU to 12000 IU per day.

EFFECT: effective treatment with lower doses compared to the currently available systemic delivery.

13 cl, 5 ex, 5 dwg, 4 tbl